MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

Noro, Rintaro; Seike, Masahiro; Zou, Fenfei; Soeno, Chie; Matsuda, Kuniko; Sugano, Teppei; Nishijima, Nobuhiko; Matsumoto, Masaru; Kitamura, Kazuhiro; Kosaihira, Seiji; Minegishi, Yuji; Yoshimura, Akinobu; Kubota, Kaoru; Gemma, Akihiko

doi:10.1186/s12885-015-1019-1

BMC Cancer

Article metrics
Last updated: Sat, 20 Apr 2024 3:08:44 Z

MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation

Access & Citations

1743

Article Accesses
25

Web of Science
24

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com